Knowledgebase · FAIRsharing

Cancer Drug Interactions

Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

Website
Record in FAIRsharing (doi:10.25504/FAIRsharing.eca8fd)
Subjects: Biomedical Science, Drug Development, Drug Discovery

What is known per question

The questions of the decision tree, with what FAIRsharing says about this repository. ✓ supported, ✗ excluded, ? not known.

What kind of data do you want to archive?

? Spectra
? Crystal structures
? Computational chemistry
? Catalysis
? Compounds and reactions
? Bioassays and chemical biology
? Materials and polymers
? Images and microscopy
? Something else

Subjects: Biomedical Science; Drug Development; Drug Discovery

Domains: cancer; disease; drug interaction

Does the journal or publisher you publish with require or recommend a repository?

? Yes
? No
? I do not know

FAIRsharing has no information on this.

Which discipline does your data belong to?

FAIRsharing has no information on this.

Which publisher?

FAIRsharing has no information on this.

Does your funder have requirements for where data is archived?

? Yes
? No
? I do not know

FAIRsharing has no information on this.

Which funder?

FAIRsharing has no information on this.

Does your institution offer a data repository?

? Yes
? No
? I do not know

FAIRsharing has no information on this.

Which institution?

FAIRsharing has no information on this.

Can your data be shared openly?

✓ Yes, openly available
? Yes, after an embargo
✗ Only with restrictions

Data access: open

Data deposition: not applicable

How large is your dataset?

? Less than 1 GB
? 1 GB to 50 GB
? 50 GB to 1 TB
? More than 1 TB

FAIRsharing has no information on this.

Why can the data not be open?

? It contains personal data
? Commercial or intellectual property reasons
? Safety or security concerns
? A data sharing agreement limits it

FAIRsharing has no information on this.

Under which license do you want to share the data?

? CC0 / public domain
? CC BY
? Another open license
? Not decided yet

Licences: Drug Interactions Terms and Conditions

Do you need a persistent identifier, such as a DOI, for citing the data?

? Yes, a DOI
? Any persistent identifier will do
? No

FAIRsharing has no information on this.

Must the data be stored in a specific region?

? In the European Union
? In a specific country
✓ No preference

Country: Netherlands; United Kingdom

Must archiving be free of charge?

? Yes, free only
? A fee is fine

FAIRsharing has no information on this.

Which country?

✓ 2 of 15 in the list ✗ excludes 13

Country: Netherlands; United Kingdom